Voyager Therapeutics (VYGR) Receivables - Other (2019 - 2025)
Voyager Therapeutics (VYGR) has disclosed Receivables - Other for 7 consecutive years, with $151000.0 as the latest value for Q4 2025.
- Quarterly Receivables - Other fell 77.66% to $151000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $151000.0 through Dec 2025, down 77.66% year-over-year, with the annual reading at $151000.0 for FY2025, 77.66% down from the prior year.
- Receivables - Other hit $151000.0 in Q4 2025 for Voyager Therapeutics, down from $851000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $3.7 million in Q3 2024 to a low of $151000.0 in Q2 2022.
- Historically, Receivables - Other has averaged $1.3 million across 5 years, with a median of $791500.0 in 2021.
- Biggest five-year swings in Receivables - Other: crashed 98.77% in 2021 and later surged 2118.54% in 2023.
- Year by year, Receivables - Other stood at $732000.0 in 2021, then crashed by 64.89% to $257000.0 in 2022, then soared by 1200.0% to $3.3 million in 2023, then plummeted by 79.77% to $676000.0 in 2024, then plummeted by 77.66% to $151000.0 in 2025.
- Business Quant data shows Receivables - Other for VYGR at $151000.0 in Q4 2025, $851000.0 in Q3 2025, and $851000.0 in Q2 2025.